Evidence That the Rab5 Effector APPL1 Mediates APP-βCTF-induced Dysfunction of Endosomes in Down Syndrome and Alzheimer's Disease

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2015 Jul 22

PMID 26194181

Citations 115

Authors

S Kim

Y Sato

P S Mohan

C Peterhoff

A Pensalfini

A Rigoglioso

Y Jiang

R A Nixon

Affiliations

Soon will be listed here.

Abstract

β-Amyloid precursor protein (APP) and its cleaved products are strongly implicated in Alzheimer's disease (AD). Endosomes are highly active APP processing sites, and endosome anomalies associated with upregulated expression of early endosomal regulator, rab5, are the earliest known disease-specific neuronal response in AD. Here, we show that the rab5 effector APPL1 (adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif) mediates rab5 overactivation in Down syndrome (DS) and AD, which is caused by elevated levels of the β-cleaved carboxy-terminal fragment of APP (βCTF). βCTF recruits APPL1 to rab5 endosomes, where it stabilizes active GTP-rab5, leading to pathologically accelerated endocytosis, endosome swelling and selectively impaired axonal transport of rab5 endosomes. In DS fibroblasts, APPL1 knockdown corrects these endosomal anomalies. βCTF levels are also elevated in AD brain, which is accompanied by abnormally high recruitment of APPL1 to rab5 endosomes as seen in DS fibroblasts. These studies indicate that persistent rab5 overactivation through βCTF-APPL1 interactions constitutes a novel APP-dependent pathogenic pathway in AD.

Citing Articles

Maternal choline supplementation rescues early endosome pathology in basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Gautier M, Kelley C, Lee S, Mufson E, Ginsberg S Neurobiol Aging. 2024; 144:30-42.

PMID: 39265450 PMC: 11490376. DOI: 10.1016/j.neurobiolaging.2024.09.002.

Accelerated long-term forgetting: A sensitive paradigm for detecting subtle cognitive impairment and evaluating BACE1 inhibitor efficacy in preclinical Alzheimer's disease.

Ohno M Front Dement. 2024; 2:1161875.

PMID: 39081986 PMC: 11285641. DOI: 10.3389/frdem.2023.1161875.

Alzheimer's disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling.

Zoltowska K, Das U, Lismont S, Enzlein T, Maesako M, Houser M Elife. 2024; 12.

PMID: 39027984 PMC: 11259434. DOI: 10.7554/eLife.90690.

Increasing the Survival of a Neuronal Model of Alzheimer's Disease Using Docosahexaenoic Acid, Restoring Endolysosomal Functioning by Modifying the Interactions between the Membrane Proteins C99 and Rab5.

Vigier M, Uriot M, Djelti-Delbarba F, Claudepierre T, El Hajj A, Yen F Int J Mol Sci. 2024; 25(13).

PMID: 38999927 PMC: 11240902. DOI: 10.3390/ijms25136816.

The amyloid precursor protein and its derived fragments concomitantly contribute to the alterations of mitochondrial transport machinery in Alzheimer's disease.

Vaillant-Beuchot L, Eysert F, Duval B, Kinoshita P, Pardossi-Piquard R, Bauer C Cell Death Dis. 2024; 15(5):367.

PMID: 38806484 PMC: 11133367. DOI: 10.1038/s41419-024-06742-2.

References

Young-Pearse T, Bai J, Chang R, Zheng J, LoTurco J, Selkoe D . A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci. 2007; 27(52):14459-69. PMC: 6673432. DOI: 10.1523/JNEUROSCI.4701-07.2007. View

Cataldo A, Barnett J, Pieroni C, Nixon R . Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci. 1997; 17(16):6142-51. PMC: 6568334. View

Nixon R . Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007; 120(Pt 23):4081-91. DOI: 10.1242/jcs.019265. View

Deinhardt K, Salinas S, Verastegui C, Watson R, Worth D, Hanrahan S . Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron. 2006; 52(2):293-305. DOI: 10.1016/j.neuron.2006.08.018. View

Cossec J, Lavaur J, Berman D, Rivals I, Hoischen A, Stora S . Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes. Hum Mol Genet. 2012; 21(14):3156-72. PMC: 3384382. DOI: 10.1093/hmg/dds142. View

Tilstra J, Clauson C, Niedernhofer L, Robbins P . NF-κB in Aging and Disease. Aging Dis. 2012; 2(6):449-65. PMC: 3295063. View

Refolo L, Malester B, Lafrancois J, Wang R, Tint G, Sambamurti K . Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis. 2000; 7(4):321-31. DOI: 10.1006/nbdi.2000.0304. View

Salehi A, Delcroix J, Belichenko P, Zhan K, Wu C, Valletta J . Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron. 2006; 51(1):29-42. DOI: 10.1016/j.neuron.2006.05.022. View

Zoncu R, Perera R, Balkin D, Pirruccello M, Toomre D, De Camilli P . A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell. 2009; 136(6):1110-21. PMC: 2705806. DOI: 10.1016/j.cell.2009.01.032. View

10.

Borg J, Ooi J, Levy E, Margolis B . The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol. 1996; 16(11):6229-41. PMC: 231626. DOI: 10.1128/MCB.16.11.6229. View

11.

Mastrocola R, Guglielmotto M, Medana C, Catalano M, Cutrupi S, Borghi R . Dysregulation of SREBP2 induces BACE1 expression. Neurobiol Dis. 2011; 44(1):116-24. DOI: 10.1016/j.nbd.2011.06.010. View

12.

Cataldo A, Peterhoff C, Troncoso J, Gomez-Isla T, Hyman B, Nixon R . Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000; 157(1):277-86. PMC: 1850219. DOI: 10.1016/s0002-9440(10)64538-5. View

13.

Ginsberg S, Alldred M, Counts S, Cataldo A, Neve R, Jiang Y . Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry. 2010; 68(10):885-93. PMC: 2965820. DOI: 10.1016/j.biopsych.2010.05.030. View

14.

Bucci C, Parton R, Mather I, Stunnenberg H, Simons K, Hoflack B . The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell. 1992; 70(5):715-28. DOI: 10.1016/0092-8674(92)90306-w. View

15.

Zhu G, Chen J, Liu J, Brunzelle J, Huang B, Wakeham N . Structure of the APPL1 BAR-PH domain and characterization of its interaction with Rab5. EMBO J. 2007; 26(14):3484-93. PMC: 1933402. DOI: 10.1038/sj.emboj.7601771. View

16.

Pimplikar S, Nixon R, Robakis N, Shen J, Tsai L . Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J Neurosci. 2010; 30(45):14946-54. PMC: 3426835. DOI: 10.1523/JNEUROSCI.4305-10.2010. View

17.

Lee M, Kao S, Lemere C, Xia W, Tseng H, Zhou Y . APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol. 2003; 163(1):83-95. PMC: 2173445. DOI: 10.1083/jcb.200301115. View

18.

Stenmark H . Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009; 10(8):513-25. DOI: 10.1038/nrm2728. View

19.

Sisodia S . Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci U S A. 1992; 89(13):6075-9. PMC: 49440. DOI: 10.1073/pnas.89.13.6075. View

20.

Tamayev R, Zhou D, DAdamio L . The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains. Mol Neurodegener. 2009; 4:28. PMC: 2723102. DOI: 10.1186/1750-1326-4-28. View